© 1999 by Oxford University Press
Journal of the National Cancer Institute, Vol. 91, No. 4, 299-301,
February 17, 1999
© 1999 Oxford University Press
EDITORIALS |
Molecular Detection of Early Lung Cancer
Affiliation of authors: Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas.
Correspondence to: Adi F. Gazdar, M.D., Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas TX 75235-8593 (e-mail: gazdar@simmons.swmed.edu).
Lung cancer is the most common cause of cancer death in the United
States, and most cases follow long-term use of tobacco products
(1,2). The first objective in lung cancer control is to
prevent persons from starting to smoke and to help those who smoke to
quit. Nevertheless, in the United States today, there are 48 million
smokers, most of whom find it difficult to quit, with new smokers
rapidly replacing the quitters (3) and smokers who die from
their disease. In addition, about 40% of all new lung cancers are
occurring in former smokers, who remain at high risk for developing
lung cancer for many years after they stop smoking (4). Under
current standard methods of diagnosis and treatment, less than 15%
of patients with lung cancer will survive their disease (2).
Most patients who achieve long-term survival are
NOTES
REFERENCES
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Baryshnikova, A. Destro, M. V. Infante, S. Cavuto, U. Cariboni, M. Alloisio, G. L. Ceresoli, R. Lutman, G. Brambilla, G. Chiesa, et al. Molecular Alterations in Spontaneous Sputum of Cancer-Free Heavy Smokers: Results from a Large Screening Program Clin. Cancer Res., March 15, 2008; 14(6): 1913 - 1919. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Regala, C. Weems, L. Jamieson, A. Khoor, E. S. Edell, C. M. Lohse, and A. P. Fields Atypical Protein Kinase C{iota} Is an Oncogene in Human Non-Small Cell Lung Cancer Cancer Res., October 1, 2005; 65(19): 8905 - 8911. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Regala, C. Weems, L. Jamieson, J. A. Copland, E. A. Thompson, and A. P. Fields Atypical Protein Kinase C{iota} Plays a Critical Role in Human Lung Cancer Cell Growth and Tumorigenicity J. Biol. Chem., September 2, 2005; 280(35): 31109 - 31115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. L. Humphrey, S. Teutsch, and M. Johnson Lung Cancer Screening with Sputum Cytologic Examination, Chest Radiography, and Computed Tomography: An Update for the U.S. Preventive Services Task Force Ann Intern Med, May 4, 2004; 140(9): 740 - 753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Mecklenburg, D. F. Stratakis, R. M. Huber, K. Haussinger, A. Morresi-Hauf, G. Riethmuller, and P. Kufer Detection of Melanoma Antigen-A Expression in Sputum and Bronchial Lavage Fluid of Patients With Lung Cancer Chest, May 1, 2004; 125(5_suppl): 164S - 166S. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Danesi, F. De Braud, S. Fogli, T. M. De Pas, A. Di Paolo, G. Curigliano, and M. Del Tacca Pharmacogenetics of Anticancer Drug Sensitivity in Non-Small Cell Lung Cancer Pharmacol. Rev., March 1, 2003; 55(1): 57 - 103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Jett Screening for Lung Cancer: No Longer a Taboo Subject J. Clin. Oncol., April 15, 2002; 20(8): 1959 - 1961. [Full Text] [PDF]
|
|
|
|
 |
|
 G. H. Fisher, S. L. Wellen, D. Klimstra, J. M. Lenczowski, J. W. Tichelaar, M. J. Lizak, J. A. Whitsett, A. Koretsky, and H. E. Varmus Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes Genes & Dev., December 15, 2001; 15(24): 3249 - 3262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Feng, X.-c. Xu, E. M. Youssef, and R. Lotan Diminished Expression of S100A2, a Putative Tumor Suppressor, at Early Stage of Human Lung Carcinogenesis Cancer Res., November 1, 2001; 61(21): 7999 - 8004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Sueoka, N. Sueoka, Y. Goto, S. Matsuyama, H. Nishimura, M. Sato, S. Fujimura, H. Chiba, and H. Fujiki Heterogeneous Nuclear Ribonucleoprotein B1 as Early Cancer Biomarker for Occult Cancer of Human Lungs and Bronchial Dysplasia Cancer Res., March 1, 2001; 61(5): 1896 - 1902. [Abstract] [Full Text]
|
|
|
|
|
|
F. R. Hirsch, W. A. Franklin, A. F. Gazdar, and P. A. Bunn Jr. Early Detection of Lung Cancer: Clinical Perspectives of Recent Advances in Biology and Radiology Clin. Cancer Res., January 1, 2001; 7(1): 5 - 22. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. J. Clayton, F. M. Scott, J. Walker, K. Callaghan, K. Haque, T. Liloglou, G. Xinarianos, S. Shawcross, P. Ceuppens, J. K. Field, et al. K-ras Point Mutation Detection in Lung Cancer: Comparison of Two Approaches to Somatic Mutation Detection Using ARMS Allele-specific Amplification Clin. Chem., December 1, 2000; 46(12): 1929 - 1938. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Palmisano, K. K. Divine, G. Saccomanno, F. D. Gilliland, S. B. Baylin, J. G. Herman, and S. A. Belinsky Predicting Lung Cancer by Detecting Aberrant Promoter Methylation in Sputum Cancer Res., November 1, 2000; 60(21): 5954 - 5958. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. M. Boiselle, A. Ernst, and D. D. Karp Lung Cancer Detection in the 21st Century: Potential Contributions and Challenges of Emerging Technologies Am. J. Roentgenol., November 1, 2000; 175(5): 1215 - 1221. [Full Text] [PDF]
|
|
|
|
|
|
G. Ferretti, G. Curigliano, U. Pastorino, A. Cittadini, G. Flamini, M. G. Calabrò, Tommaso De Pas, L. Orlando, M. Mandalà, M. Colleoni, et al. Detection by Denaturant Gradient Gel Electrophoresis of Tumor-specific Mutations in Biopsies and Relative Bronchoalveolar Lavage Fluid from Resectable Non-Small Cell Lung Cancer Clin. Cancer Res., June 1, 2000; 6(6): 2393 - 2400. [Abstract] [Full Text]
|
|
|
|
 |
|
 F. P. Perera and I.B. Weinstein Molecular epidemiology: recent advances and future directions Carcinogenesis, March 1, 2000; 21(3): 517 - 524. [Abstract] [Full Text] [PDF]
|
|